The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup.

Author: DioknoA C, GonzalezJ A, PetersK M, SteinertB W

Paper Details 
Original Abstract of the Article :
Interstitial cystitis is a severe debilitating bladder disease characterized by unrelenting pelvic pain and urinary frequency. A prospective, double-blind, placebo controlled study of the use of intravesical bacillus Calmette-Guerin (BCG) in the treatment of interstitial cystitis was recently comple...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00005392-199805000-00019

データ提供:米国国立医学図書館(NLM)

Intravesical Bacillus Calmette-Guerin (BCG): A Beacon of Hope in the Desert of Interstitial Cystitis

Interstitial cystitis (IC), a chronic and debilitating bladder condition, is like a relentless sandstorm in the body, causing pain and discomfort. This study examines the long-term effects of intravesical BCG therapy, a potential oasis in the desert of IC treatment. The authors conducted a prospective, double-blind, placebo-controlled study to assess the effectiveness of BCG in treating IC. Their findings revealed a significant response rate to BCG, offering hope for patients struggling with this debilitating condition.

Long-Term Benefits of BCG Therapy

The long-term follow-up results of this study demonstrate the potential for BCG therapy to provide sustained relief for IC patients. The researchers observed a significant response rate to BCG treatment, highlighting the potential for this therapy to improve quality of life for patients with IC. This study provides valuable insights into the long-term efficacy of BCG therapy, offering hope for patients who have struggled to find effective treatments.

A New Oasis in the Desert of IC Treatment

This research is a testament to the ongoing quest for better therapies for IC. Just as a desert explorer seeks out oases for sustenance, researchers are constantly searching for effective treatments for this debilitating condition. This study offers a beacon of hope for IC patients, providing evidence of the potential for BCG therapy to provide long-term relief from symptoms.

Dr. Camel's Conclusion

This research is a reminder that even in the vast and arid desert of IC, there are oases of hope. Just as a camel relies on its resilience to navigate the challenging desert environment, IC patients can find solace in the promise of effective therapies like BCG. This research is a beacon of light, illuminating the path towards better management and treatment options for patients with IC.

Date :
  1. Date Completed 1998-04-29
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

9554338

DOI: Digital Object Identifier

10.1097/00005392-199805000-00019

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.